Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 730-736

  Garg, Renu ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiotensin II; Gene expression; Gene transcription; Mesangial cells; Natriuretic peptide receptor; Promoter analysis

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; CANDESARTAN; MESSENGER RNA; PEPTIDE; VASOACTIVE AGENT;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENETIC CODE; GENETIC SELECTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TRANSCRIPTION INITIATION SITE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION; GUANYLATE CYCLASE; MICE; PROMOTER REGIONS (GENETICS); RECEPTORS, ATRIAL NATRIURETIC FACTOR; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0037338683     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000051890.68573.94     Document Type: Conference Paper

References (44)

1. Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem. 1991;60:229-255.
2. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
4. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell. 1992;71:1-4.
5. Pandey KN. Vascular action: Natriuretic peptide receptor. In: Sowers JR, ed. Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:255-267.
6. Anand-Srivastava MB, Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev. 1993;45:455-497.
7. Hirata Y, Tomita M, Takada S, Yoshimi H. Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP. Biochem Biophys Res Commun. 1985;128:538-546.
8. Cao L, Wu J, Gardner DG. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem. 1995;270:24891-24897.
9. Pandey KN, Nguyen HT, Sharma GD, Shi SJ, Kriegel AM. Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J Biol Chem. 2002;277:4618-4627.
10. Lanier-Smith KL, Currie MG. Glucocorticoid regulation of atrial natriuretic peptide receptors on cultured endothelial cells. Endocrinology. 1991;129:2311-2317.
11. Smith JB, Lincoln TM. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol. 1987;253:C147-C150.
12. Haneda M, Kikkawa R, Maeda S, Togawa M, Koya D, Horide N, Kajiwara N, Shigeta Y. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int. 1991;40:188-194.
13. Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, de Gasparo M. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun. 1992;183:206-211.
14. 1 in cultured aortic smooth muscle cells. Hypertension. 1994;23:908-913.
15. 1 on the gene expression of atrial natriuretic peptide biological and clearance receptors in a murine thymic stromal cell line. J Biochem (Tokyo). 1995;118:500-507.
16. Cachofeiro V, Schiffrin EL, Cantin M, Garcia R. Glomerular and vascular atrial natriuretic factor receptors in adrenalectomized rats. Am J Physiol. 1989;256:R1250-R1257.
17. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation. 1993;87:70-75.
18. Katafuchi T, Mizuno T, Hagiwara H, Itakura M, Ito T, Hirose S. Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells. J Biol Chem. 1992;267:7624-7629.
19. Chen S, Gardner DG. Osmoregulation of natriuretic peptide receptor signaling in inner medullary collecting duct: a requirement for p38 MAPK. J Biol Chem. 2002;277:6037-6043.
20. de Arriba G, Barrio V, Olivera A, Rodriguez-Puyol D, Lopez-Novoa JM. Atrial natriuretic peptide inhibits angiotensin II-induced contraction of isolated glomeruli and cultured glomerular mesangial cells of rats: the role of calcium. J Lab Clin Med. 1988;111:466-474.
21. Kumar R, Cartledge WA, Lincoln TM, Pandey KN. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells: role of cGMP-and cGMP-dependent protein kinase. Hypertension. 1997;29:414-421.
22. Pandey KN, Nguyen HT, Li M, Boyle JW. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem Biophys Res Commun. 2000;271:374-379.
23. Elliott ME, and Goodfriend TL. Inhibition of aldosterone synthesis by atrial natriuretic factor. Federation Proc. 1986;45:2376-2381.
24. Sumners C, Tang W, Zelezna B, Raizada MK. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA. 1991;88:7567-7571.
25. Chabrier PE, Roubert P, Lonchampt MO, Plas P, Braquet P. Regulation of atrial natriuretic factor receptors by angiotensin II in rat vascular smooth muscle cells. J Biol Chem. 1988;263:13199-13202.
26. Foidart J, Sraer J, Delarue F, Mahieu P, Ardaillou R. Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility. FEBS Lett. 1980;121:333-339.
27. Ballermann BJ, Hoover RL, Karnovsky MJ, Brenner BM. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest. 1985;76:2049-56.
28. Garg R, Oliver PM, Maeda N, Pandey KN. Genomic structure, organization, and promoter region analysis of murine guanylyl cyclase/atrial natriuretic peptide receptor-A gene. Gene. 2002;291:123-133.
29. Throckmorton DC, Dickinson M, Dransfield DT. Type IA-kinase is activated by platelet-derived growth factor in mesangial cells. Biochem Biophys Res Commun. 1996;220:692-696.
30. Pandey KN, Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem. 1990;265:12342-12348.
31. 1 receptors: expression, signaling, and regulation. J Am Soc Nephrol. 1999;10(suppl II):S40-S46.
32. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
33. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
34. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
35. 2 in vascular smooth muscle cells: molecular mechanisms. Circ Res. 2000;23:1266-1272.
36. 1 receptor knockout mice. J Am Soc Nephrol. 2002;13:1162-1171.
37. 2 receptor mediated P-selectin upregulation. Circulation. 2000;102:2118-2123.
38. Ofir R, Dwarki VJ, Rashid D, Verma IM. CREB represses transcription of fos promoter: role of phosphorylation. Gene Expr. 1991;1:55-60.
39. Giono LE, Varone CL, Canepa ET. 5-aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB). Biochem J. 2001;353:307-316.
40. Vallejo M, Gosse ME, Beckman W, Habener JF. Impaired cyclic AMP-dependent phosphorylation renders CREB a repressor of C/EBP-induced transcription of the somatostatin gene in an insulinoma cell line. Mol Cell Biol. 1995;15:415-424.
41. Lemaigre FP, Ace CI, Green MR. The cAMP response element binding protein, CREB, is a potent inhibitor of diverse transcriptional activators. Nucleic Acids Res. 1993;21:2907-2911.
42. Jard S, Cantau B, Jakobs KH. Angiotensin II and α-adrenergic agonists inhibit rat liver adenylate cyclase. J Biol Chem. 1981;256:2603-2606.
43. 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
44. Fakhouri F, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C. Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-β. J Am Soc Nephrol. 2001;12:2701-2710.